Skip to content

Effect of levothyroxine on the prognosis of children with PNS

Effect of levothyroxine on the prognosis of children with PNS

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038353
Enrollment
Unknown
Registered
2020-09-21
Start date
2020-09-30
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary nephrotic syndrome

Interventions

trial group:NS basic treatment + LT4 replacement therapy
control group:after NS basic treatment for 3 weeks, LT4 replacement therapy was started

Sponsors

Chidren's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 1 to 16 years; 2. They met the diagnostic criteria for primary nephrotic syndrome (PNS) in accordance with the "evidence-based guidelines for the diagnosis and treatment of steroid sensitive, relapsed / dependent nephrotic syndrome (2016)" issued by the nephrology group of the scientific branch of Chinese Medical Association in 2016; 3 It meets the diagnostic criteria of hypothyroidism (including clinical hypothyroidism and subclinical hypothyroidism) in the guidelines for diagnosis and treatment of adult hypothyroidism published by endocrinology branch of Chinese Medical Association in 2017.

Exclusion criteria

Exclusion criteria: Contraindications of levothyroxine sodium tablets (LT4).

Design outcomes

Primary

MeasureTime frame
Incidence rate of steroid resistant nephrotic syndrome;

Countries

China

Contacts

Public ContactLi Huarong

Chidren's Hospital Affiliated to Capital Institute of Pediatrics, Beijing, China

518lhr@163.com+86 13681030123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026